Case Review Form

      * Denotes required field.


      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address




      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

Parker Waichman LLP Files Lawsuit, Alleges Actos Caused Bladder Cancer in NC Man

Filed January 7th, 2013 admin

The national law firm, Parker Waichman LLP, has filed a lawsuit on behalf of a North Carolina man who developed bladder cancer, allegedly as the result of using the Type 2 diabetes drug, Actos, and names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc. f/k/a Takeda Pharmaceuticals North America Inc., Takeda Pharmaceutical Company Limited, and Eli Lilly and Company as defendants.

The lawsuit was filed on November 16 in the U.S. District Court for the Western District of Louisiana, Lafayette Division, where it pending in a multidistrict litigation (MDL). The lawsuit cites a U.S. Food and Drug Administration (FDA) statement, claiming that that use of Actos for more than one year may be associated with an increased risk of bladder cancer.

According to the lawsuit, the man began taking Actos in 2002 and shortly after he developed bladder cancer. The lawsuit alleges that the plaintiff suffered a number of damages as a result of using Actos, including severe mental and physical pain and suffering, permanent injuries, emotional distress, and economic loss. The suit is also alleging loss of consortium on behalf of the man’s wife.

According to the lawsuit, the defendants knew Actos could increase the risk of bladder cancer, yet failed warn the plaintiff or the public of the risks. The lawsuit claims that the man would not have taken Actos if he had been aware of the risks. The FDA recently updated the warning label on Actos, warning that use of the drug for more than one year may be associated with a higher risk of bladder cancer.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!